Absolutely... akin to physicians throwing IL6 blockers at every Covid case early on (we know how that turned out - studies stopped due to safety and lack of efficacy). Brute force / trial and error hasn't yielded any miracles yet. So I'm assuming Drs. P and Yo are going to have some extremely specific findings on which steroids have which effects on which indications... based from fairly extensive examination of the patients blood samples.

I don't expect any signals to be clear or strong, but still interested in what they believe they've found.

And it likely has little to no bearing on LLMab needing to have a Long Hauler study. "Heterogenous" means not everyone is going to respond the same way (why IncellDX's diagnostics will no doubt feature heavily).